Reducing Cardiovascular Complication Risk in People Living with HIV: Lessons from the REPRIEVE Trial

Internal Medicine Grand Rounds

Thursday, July 31, 2025 at 12:00 PM


This grand round has already taken place.


DHLRI 170 - Columbus, OH
July 31st, 2025
1.00 AMA PRA Category 1 Credit Hours

Description

Carlos Malvestutto, MD, MPH, FIDSA   

The Ohio State University

Dates and Times

Start: 7/31/2025 12:00 PM
End: 7/31/2025 1:00 PM

Objectives

1. To understand the incidence and Etiology of heart disease in people living with HIV.

2. To review the evidence of the impact of Pitavastatin of heart disease risk based on the results of the REPRIEVE trial.

3. To highlight key study design and implementation features of the REPRIEVE trial.

Speakers

  • Carlos Malvestutto, MD
    • Reducing Cardiovascular Complication Risk in People Living with HIV: Lessons from the REPRIEVE Trial

Location

DHLRI 170
473 W 12th Ave
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Need help with this Grand Round Session?

Please contact the Grand Round coordinator listed below:

Maggie Murray
Department: Internal Medicine
Phone: (614) 293-3989
Email: Maggie.Murray@osumc.edu